These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30045335)

  • 1. Prognostic significance of lymph node ratio in node-positive cervical cancer patients.
    Joo JH; Kim YS; Nam JH
    Medicine (Baltimore); 2018 Jul; 97(30):e11711. PubMed ID: 30045335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
    Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
    J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study.
    Mansouri H; Zemni I; Sakhri S; Ayadi MA; Boujelbene N; Ben Dhiab T
    Womens Health (Lond); 2024; 20():17455057241285396. PubMed ID: 39340307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study.
    Ye Y; Lian R; Li Z; Chen X; Huang Y; Yao J; Lu A; Lang J; Liu P; Chen C
    BMC Cancer; 2024 Aug; 24(1):1005. PubMed ID: 39138415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
    Kwon J; Eom KY; Kim YS; Park W; Chun M; Lee J; Kim YB; Yoon WS; Kim JH; Choi JH; Chang SK; Jeong BK; Lee SH; Cha J
    Cancer Res Treat; 2018 Jul; 50(3):964-974. PubMed ID: 29081219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
    Jung W; Kim K; Kim J; Shim SJ
    In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
    Fan X; Wang Y; Yang N; Zhu P
    World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
    Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
    Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
    Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.
    Fleming ND; Frumovitz M; Schmeler KM; dos Reis R; Munsell MF; Eifel PJ; Soliman PT; Nick AM; Westin SN; Ramirez PT
    Gynecol Oncol; 2015 Jan; 136(1):48-53. PubMed ID: 25451695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue?
    Bharath VM; Balagopal PG; Nebu AG; Jayasudha AV; Iqbal Ahmed M; Sebastian P
    Gulf J Oncolog; 2018 Sep; 1(28):6-10. PubMed ID: 30344127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph Node Ratio Can Better Predict Prognosis than Absolute Number of Positive Lymph Nodes in Operable Cervical Carcinoma.
    Widschwendter P; Polasik A; Janni W; de Gregorio A; Friedl TWP; de Gregorio N
    Oncol Res Treat; 2020; 43(3):87-95. PubMed ID: 31935729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
    Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.